Multiple sclerosis (MS) is a demyelinating autoimmune disease of the central nervous system. A new study has shown that the lipid lactosylceramide, produced by astrocytes, contributes to disease progression in a mouse model of MS.
References
Wingerchuk, D.M. & Carter, J.L. Mayo Clin. Proc. 89, 225–240 (2014).
Nair, A., Frederick, T.J. & Miller, S.D. Cell. Mol. Life Sci. 65, 2702–2720 (2008).
Simmons, S.B., Pierson, E.R., Lee, S.Y. & Goverman, J.M. Trends Immunol. 34, 410–422 (2013).
Mayo, L. et al. Nat. Med. 20, 1147–1156 (2014).
Chatterjee, S., Kolmakova, A. & Rajesh, M. Curr. Drug Targets 9, 272–281 (2008).
Pannu, R., Singh, A.K. & Singh, I. J. Biol. Chem. 280, 13742–13751 (2005).
El-Behi, M. et al. Nat. Immunol. 12, 568–575 (2011).
Kim, R.Y. et al. J. Neuroimmunol. 274, 53–61 (2014).
Applebee, A. & Panitch, H. Biologics 3, 257–271 (2009).
Chatterjee, S. et al. Circulation 129, 2403–2413 (2014).
Fujiwara, H. et al. Biomed. Res. 33, 265–271 (2012).
Akasako, Y., Nara, K., Nagai, Y. & Hashimoto, Y. Neurosci. Lett. 488, 199–203 (2011).
Chatterjee, S. & Pandey, A. Biochim. Biophys. Acta 1780, 370–382 (2008).
Kumagai, T. et al. Biochem. Biophys. Res. Commun. 379, 456–459 (2009).
Tokuda, N. et al. Glycobiology 23, 1175–1183 (2013).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Rostami, A., Ciric, B. Astrocyte-derived lactosylceramide implicated in multiple sclerosis. Nat Med 20, 1092–1093 (2014). https://doi.org/10.1038/nm.3719
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.3719
- Springer Nature America, Inc.
This article is cited by
-
Hippocampal neuroplasticity and inflammation: relevance for multiple sclerosis
Multiple Sclerosis and Demyelinating Disorders (2017)